Multiple Myeloma Archives - Virginia Cancer Specialists

Search Our Trials

At Virginia Cancer Specialists (VCS), research is a vital part of our mission to provide patients access to advanced cancer treatments and clinical trials in the community where they live and work.

Visit Clinicaltrials.gov Virginia Cancer Specialists Search for more information

Find A Clinical Trial

Disease Type: Multiple Myeloma

Trial ID 21273

Sponsor ID GS-US-558-5915

“GS-US-558-5915: A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma”

Principal Investigator

Mitul Gandhi, MD

3 Locations

Multiple Myeloma

Trial ID EZM0414

Sponsor ID SET-101

A Phase 1b Dose Escalation and Dose Expansion Study Evaluating the Safety, Pharmacokinetics, and Antitumor Activity of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations

Principal Investigator

Mitul Gandhi, MD

1 Location

Lymphoma

Multiple Myeloma

Trial ID USOR 20285

Sponsor ID Karyopharm Therapeutics

A Phase 2 Trial of Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Combination with Selinexor For Patients with Newly Diagnosed Multiple Myeloma

Principal Investigator

Mitul Gandhi, MD

4 Locations

Multiple Myeloma

Trial ID 19247

Sponsor ID Janssen

A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant (54767414MMY3021)

Principal Investigator

Mitul Gandhi, MD

5 Locations

Multiple Myeloma